| Application no. and date | 13811121.6 (espacenet) (Federated) (European Patent Register), 20131122 | | Patent/reg. no. and date | DK/EP 2925369, 20180103 | | Publication date | 20151007 | | Priority no. and date | IT MI20122027, 20121128 | | EP pub. no. and date |
EP 2925369 20151007 | | Effective date | | | Applicant/owner | Altergon S.a., Via Dogana Vecchia 2
6900 Lugano, CH | | Applicant ref. no. | P81801094DK00E | | Inventor | BERNAREGGI, Alberto, c/o ALTERGON S.A.
Via Dogana Vecchia 2
CH-6900 Lugano, CH,
PUPPINI, Nadia, c/o Altergon S.A.
Via Dogana Vecchia 2
CH-6900 Lugano, CH,
NENCIONI, Alessandro, c/o Altergon S.A.
Via Dogana Vecchia 2
CH-6900 Lugano, CH | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/568 (2006.01) , A61K 31/57 (2006.01) , A61K 47/69 (2017.01) , A61K 9/08 (2006.01) , A61P 15/08 (2006.01) , A61P 5/34 (2006.01) | | Title | VANDIGE ORALE OPLØSNINGER AF STEROIDHORMONER OG HYDROXYPROPYL-BETA-CYCLODEXTRIN MED OPTIMERET BIOTILGÆNGELIGHED | | Int. application no. | EP2013003538 | | Int. publication no. | WO2014082724 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
